Synthesis Of Dibenzofuran-1,3-Thiazole Carboxamide Derivatives And Screened For Anti-Inflammatory Potential

  • Shubham Singh
  • Dr. Arun Patel
  • Dr. Shailendra Patel
Keywords: Thiazole, Anti-inflammatory, Protein Denaturation Assay

Abstract

Objective: Synthesis of dibenzofuran-1,3-thiazole carboxamide derivatives and screened for anti-inflammatory potential

Material and methods: The goal of the current study was to synthesize a few dibenzofuran-1,3thiazolecarboxamide derivatives using four-step processes and several substituted benzylamines with the help of an appropriate catalyst. The following compounds were prepared: compound 1 (S-((4-chlorodibenzo[b,d]furan-1-yl)methyl) thiohydroxylamine), compound 2 (ethyl 2-(4 chlorodibenzo[b,d]furan-1-yl)-5-methylthiazole-4-carboxylate), compound 3 (2-(4-chlorodibenzo[b,d]furan-1-yl)-5 methylthiazole-4-carboxylic acid), and compound 4 (N-benzyl-2-(4-chlorodibenzo[b,d] furan-1-yl)-5-methyl thiazole 4-carboxamide). Compounds TC-1 through TC-14 are the codes for Compound 4. A total of twelve compounds have been created in these four processes, and the protein denaturation assay has been used to assess each compound's potential for reducing inflammation.

Result and Discussion: The IR spectrum of the compounds has shown the characteristics peak (cm-1) of N-H at 3412; C=C-H at 3470; C=O at 1735; C=C at 1624–1446; C-N at 1015; p-substitution at 792; C-F at 1102; C-Cl at 855; C-Br at 1015; N-O at 1356; N=O at 1558. The 1HNMR spectra of Final compounds (TC-1 to TC-12) depicted the peak at 2.90 (3H, CH3); 4.64 - 4.65 (2H, CH2); 7.05-7.10 (2H, Ar-H); 7.35 (1H, Ar-H); 7.33 – 7.39 (4H, Ar-H); 7.45 (1H, Ar-H); 7.48 - 7.50 (1H, Ar-H); 7.62 - 7.63 (1H, Ar-H); 7.90 - 7.92 (1H, Ar-H); 8.38 – 8.40 (1H, N-H). Compound TC-1, mass spectrum has shown peak at m/z = 450.85, which matches the chemical formula C24H16ClFN2O2S. The protein denaturation assay of synthesized compound stated that most active compound are TC-1, TC-2, TC-3, TC-4 and TC-5 and compounds TC-7 & TC-9 has shown the mild activity and compound TC-6, TC-8, TC-10, TC-11 and TC-12 has shown modest activity.

Conclusion: The substitution of fluoro, chloro, bromo, iodo, and nitro was one of the main groups that significantly increased the activity with para-substituent.

Author Biographies

Shubham Singh

SRGI- Shri Ram Group of Institution, Department of pharmacy, Jabalpur-482002, Madhya Pradesh, India

Dr. Arun Patel

SRGI- Shri Ram Group of Institution, Department of pharmacy, Jabalpur-482002, Madhya Pradesh, India

Dr. Shailendra Patel

SRGI- Shri Ram Group of Institution, Department of pharmacy, Jabalpur-482002, Madhya Pradesh, India

References

1. Eleftheriou P, Geronikaki A, Hadjipavlou-Litina D, Vicini P, Filz O, Filimonov D, Poroikov V,Chaudhaery SS, Roy KK, Saxena AK. Fragment-based design, docking, synthesis,biological evaluation and structure-activity relationships of 2-benzisothiazolimino-5-aryliden-4-thiazolidinones as cyclooxygenase lipoxygenase inhibitors. Eur J Med Chem. 2012;47: 111–124.
2. MylariBL, Larson ER, Beyer TA. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid and congeners, JMedChem 1991; 34(1): 108–122.
3. Van Zandt MC, Jones ML,Gunn DE. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. JMedChem 2005; 48(9): 3141–3152
4. Sherif SM, Mohareb RM, Shams HZ, Gaber HM. A convenient synthesis of polyfunctionally substituted benzo [b]thiophen-2-yl-pyrimidine, -pyrazole, -isoxazole and pyridazine derivatives. JChem Res1995;11:434-435.
5. Bansal S, Bala M, Suthar SK, Choudhary S, Bhattacharya S, Bhardwaj V, Singla S, Joseph A.Designand synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4oxadiazoles as selective COX-2inhibitors with potent anti-inflammatory activity. Eur JMed Chem2014;80:167–174.
6. Penrose JF, Austen KF, Lam BK. Leukotrienes: Biosynthetic Pathways, Release and Receptor-MediatedActions with Relevance to Disease States. In Inflammation: Basic Principles and Clinical Correlates; Gallin JL,Snyderman R, Eds.; Lippicort Williams & Wilkins: Philadelphia, PA, USA, 1999; pp. 361–372
7. Bondock S, Fouda AM. Synthesis and evaluation of some new 5-arylthiazoles as potential antimicrobial agents. SynthCommun2018;48: 561–573.
8. Ashok D, SreeKanth S, Sarasija M, Vijiulatha M. Synthesis biologicalevaluation and molecular docking of spirofurochromanone derivative as anti-inflammatory and anti-oxidant agents. Royal Society Chem 2017; 7: 5710-25724
9. Gopal B, Sukunath N, Lavanya A, Thirunavukarasu S.In-vivo effective dibenzo(b,d)furan-1-yl-thiazoles as novel PDE-4 inhibitors.Bioorg MedChem 2016; 24: 5702-5716.
10. Mohareb RM, Zaki MY, Abbas NS. Synthesis, anti-inflammatory and anti-ulcer evaluations of thiazole, thiophene, pyridine and pyran derivatives derived from androstenedione. Steroids2015;98: 80–91.
11. Srinivas K, Thirumal Y, Govardhan S, Balasubramanian A. Synthesis ofantitubercular evalution of novel dibenzo(b,d)furan and 9-methyl-9H-Carbazole derived hexahydro-2H-Pyrano(3,2-c)quinolones via povarov reaction. EurJMed Chem 2016;46: 4827-4833.
12. Sangita C, Priyanka C, Protapaditya D, Sanjib B.Evaluation of invitro anti-inflammatory activity of coffee against the denaturation of protein.Asian Pacific JTrop Biomed2012; 3(2):178-180.
Published
2024-08-24
How to Cite
Shubham Singh, Dr. Arun Patel, & Dr. Shailendra Patel. (2024). Synthesis Of Dibenzofuran-1,3-Thiazole Carboxamide Derivatives And Screened For Anti-Inflammatory Potential. Revista Electronica De Veterinaria, 25(1), 809-823. Retrieved from https://www.veterinaria.org/index.php/REDVET/article/view/716
Section
Articles